Cell Therapy for Parkinson's Disease: Only Young Onset Patients Allowed? Reflections about the Results of Recent Clinical Trials with Cell Therapy and the Progression of Parkinson's Disease
The selection of the best candidates for surgery among Parkinson's disease (PD) patients is a debated topic. This could be particularly important for transplantation studies in which patients with advanced PD and motor complications refractory to conventional pharmacological treatments are usua...
Main Author: | Gurutz Linazasoro |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2006-07-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/000000006783981792 |
Similar Items
-
Young onset of Parkinson's disease and juvenile parkinsonism
by: Quinn, Niall
Published: (1988) -
Cell Therapy for Parkinson’s Disease
by: Takao Yasuhara, et al.
Published: (2017-09-01) -
The Preclinical Research Progress of Stem Cells Therapy in Parkinson’s Disease
by: Jun Zhang, et al.
Published: (2016-01-01) -
Advantages and Recent Developments of Autologous Cell Therapy for Parkinson’s Disease Patients
by: Teresia M. Osborn, et al.
Published: (2020-04-01) -
Increased Mortality in Young-Onset Parkinson’s Disease
by: Eldbjørg Hustad, et al.
Published: (2021-09-01)